Stock listing

MRK Stock Price, News, Filings & Events — Merck & Company, Inc.

Selected listing: MRK · TSX · CAD · CA

MRK:TSX represents Merck & Company, Inc., a prominent American pharmaceutical firm with a market capitalization of around $323.72 billion. The company focuses on developing innovative healthcare solutions, including prescription medicines, vaccines, and biologic therapies aimed at enhancing patient outcomes. Recent news and filings may provide insights into Merck's ongoing projects and market strategies, reflecting its position in the competitive pharmaceutical landscape. Investors can stay informed about upcoming events that may impact the company's performance and market presence.

MRK:TSXCADCAUpdated July 31, 2026
Merck & Company, Inc. logo
Ticker
MRK:TSX
Asset type
Stock
Market cap
$321.57B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TSX
Currency
CAD

Merck & Company, Inc. MRK:TSX stock context

MRK:TSX represents Merck & Company, Inc., a prominent American pharmaceutical firm with a market capitalization of around $323.72 billion. The company focuses on developing innovative healthcare solutions, including prescription medicines, vaccines, and biologic therapies aimed at enhancing patient outcomes. Recent news and filings may provide insights into Merck's ongoing projects and market strategies, reflecting its position in the competitive pharmaceutical landscape. Investors can stay informed about upcoming events that may impact the company's performance and market presence.

Research Merck & Company, Inc.

Alternate listings